Utah Medical Products UTMD Number of Exercisable Options
Number of Exercisable Options at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's number of exercisable options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Utah Medical Products's number of exercisable options?
- Utah Medical Products (UTMD) reported number of exercisable options of 65K in Q4 2025.
- How has Utah Medical Products's number of exercisable options changed year-over-year?
- Utah Medical Products's number of exercisable options increased by 25.0% year-over-year, from 52K to 65K.
- What is the long-term trend for Utah Medical Products's number of exercisable options?
- Over 5 years (2020 to 2025), Utah Medical Products's number of exercisable options has grown at a 14.5% compound annual growth rate (CAGR), from 33K to 65K.
- What does number of exercisable options mean?
- The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.